Balanced news tone
News Sentiment
UTMD sentiment intelligence
Utah Medical Products Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-6.6% over one week, +0.6% over four weeks, trend active, and near fair-value range.
(UTMD) and the Role of Price-Sensitive Allocations
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
(UTMD) and the Role of Price-Sensitive Allocations
An analysis of Utah Medical Products Inc. (NASDAQ: UTMD) reveals weak near-term sentiment but strong mid and long-term outlooks, with an exceptional 27.8:1 risk-reward setup targeting an 8.2% gain. The article offers three AI-generated institutional trading strategies—Position Tr
- Tone
- Positive 67/100
- Event
- Market update
- Published
- 10 Jul 2026 14:50
- Source
- Stock Traders Daily
Utah Medical Products focuses on specialized devices as investors track long-term growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 19:52
- Source
- Ad Hoc News
Enterprise value to revenue forward of Utah Medical Products, Inc. – NASDAQ:UTMD
This article focuses on the enterprise value to revenue forward metric for Utah Medical Products, Inc. (NASDAQ: UTMD). The content appears to be a financial data point or a section from a larger financial analysis tool, providing specific period values for this metric without fur
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 00:09
- Source
- TradingView
Price to earnings forward of Utah Medical Products, Inc. – NASDAQ:UTMD
This article provides financial data for Utah Medical Products, Inc. (NASDAQ: UTMD), specifically focusing on its forward price-to-earnings ratio. It indicates the stock's performance and financial metrics as of a specific period, noting if the market is closed or if there are no
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 21:12
- Source
- TradingView
Enterprise value to EBITDA forward of Utah Medical Products, Inc. – NASDAQ:UTMD
This article provides financial information for Utah Medical Products, Inc. (NASDAQ: UTMD), specifically focusing on its enterprise value to EBITDA forward metric. It highlights the company's stock information on the Nasdaq Stock Market and is presented within the TradingView pla
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 10:10
- Source
- TradingView
Enterprise value to EBIT forward of Utah Medical Products, Inc. – NASDAQ:UTMD
This article provides financial information for Utah Medical Products, Inc. (NASDAQ: UTMD), focusing on its enterprise value to EBIT forward. It indicates the latest financial health of the company as of the market close with no trades reported. The content is presented within th
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 08:09
- Source
- TradingView
Form 4 Utah Medical Products Inc For: 1 July By Investing.com
This article from Investing.com reports that a Form 4 for Utah Medical Products Inc. (UTMD) has been filed for July 1st. The filing pertains to insider trading activity for the specified company and date. The article itself provides minimal detail beyond this announcement.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 22:40
- Source
- Investing.com India
Price to sales forward of Utah Medical Products, Inc. – NASDAQ:UTMD
This article provides financial information for Utah Medical Products, Inc. (NASDAQ: UTMD), specifically focusing on its "Price to sales forward" metric. It appears to be a financial data snippet from TradingView, indicating the company's valuation based on future sales.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 08:10
- Source
- TradingView
Price to book forward of Utah Medical Products, Inc. – NASDAQ:UTMD
The article title indicates that it likely discusses the "Price to book forward" metric for Utah Medical Products, Inc. (NASDAQ:UTMD). However, the body of the article appears to be primarily composed of navigation links and website boilerplate, rather than specific financial ana
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 00:41
- Source
- TradingView
UTAH MEDICAL PRODUCTS (UTMD) director reports 150-share bona fide stock gift
UTAH MEDICAL PRODUCTS INC (UTMD) director Paul O. Richins reported an indirect bona fide gift of 150 shares of Common Stock, valued at $73.07 per share. Following this transaction, Richins's indirect holdings total 20,765 shares, held across various accounts including IRAs and th
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 15:39
- Source
- Stock Titan
Responsive Playbooks and the UTMD Inflection
Utah Medical Products Inc. (NASDAQ: UTMD) is experiencing a breakout with strong near-term sentiment and compelling upside potential. AI-driven models provide tailored trading strategies including position trading, momentum breakout, and risk hedging, alongside multi-timeframe si
- Tone
- Positive 77/100
- Event
- Market update
- Published
- 29 Jun 2026 13:42
- Source
- Stock Traders Daily
Utah Medical Products (UTMD) Surges Over 10%: Key Levels to Watch - Long Short Pair
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- dars.gov.et
Utah Medical Products (UTMD) Gains Nearly 2% as Stock Approaches Key Resistance Level - Call Resistance
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- dars.gov.et
Utah Medical Products Inc (UTMD) Institutional Confidence
Utah Medical Products Inc (UTMD) has an institutional shareholding score of 7.00, placing it 79th out of 204 in the Healthcare Equipment & Supplies industry. Institutional shareholding proportion recently increased by 8.51% quarter-over-quarter to 76.75%. Bill Nygren | OAKMX is t
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 23 Jun 2026 04:10
- Source
- TradingKey
Utah Medical Products (UTMD) Shows Resilience: Gains 2% as It Eyes Key Resistance - Price Target
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 21 Jun 2026 07:00
- Source
- DonanımHaber
Utah Medical Products Inc (UTMD) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article details the dividend history and stock split information for Utah Medical Products Inc (UTMD). It provides a comprehensive table of past and upcoming dividend payments, including record dates, payment dates, and ex-dividend dates, along with the gross cash dividend a
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 19 Jun 2026 10:10
- Source
- TradingKey
Utah Medical Products Inc (UTMD) Valuation: PE, PB & Fair Value Analysis
The article provides a valuation analysis of Utah Medical Products Inc (UTMD), stating its current valuation score is 7.89, ranking 125 out of 203 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of 19.82, noting it's below a recent h
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 06:10
- Source
- TradingKey
Utah Medical Products Inc (UTMD) Shareholder Structure: Major Shareholders & Institutional Holdings
The article details the shareholder structure of Utah Medical Products Inc (UTMD), listing its major institutional and individual holders, updated as of specific dates in 2025 and 2026. It presents institutional holding trends over several quarters and lists ETFs that include UTM
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 18:09
- Source
- TradingKey
Utah Medical Products Stock - Thursday chart snapshot and volatility check
Utah Medical Products (UTMD) stock traded in a relatively tight range on Thursday, fluctuating between $65 and $67 with muted short-term volatility. The company, which specializes in medical devices for obstetrics, gynecology, and neonatal intensive care, saw its shares trade aro
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 15:09
- Source
- AD HOC NEWS
Utah Medical Products Inc (UTMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for Utah Medical Products Inc (UTMD), categorizing its revenue by business segment and geographical region. The company's main business segments are Gynecology/Electrosurgery/Urology, Neonatal, Blood Pressure Monitoring and Acces
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 13:09
- Source
- TradingKey
Utah Medical Products Inc (UTMD) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Utah Medical Products Inc (UTMD), noting that no earnings forecast score is currently available for the company from TradingKey. It highlights the stock's current market data, including its market cap, P/E ratio, and recent price mov
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Jun 2026 22:40
- Source
- TradingKey
Utah Medical Products Inc (UTMD) Risk Assessment: Volatility, Financial Risk & Investment Risk
|
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 05:39
- Source
- TradingKey
Utah Medical Products Inc (UTMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Utah Medical Products Inc (UTMD), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that UTMD is currently trading in a range-bound manner, with indicators mostly signaling "Se
- Tone
- Negative 35/100
- Event
- Market update
- Published
- 17 Jun 2026 01:40
- Source
- TradingKey
The Technical Signals Behind (UTMD) That Institutions Follow
This article from Stock Traders Daily discusses the technical signals for Utah Medical Products Inc. (NASDAQ: UTMD), highlighting strong sentiment across all horizons and an exceptional 24.6:1 risk-reward setup. It outlines three distinct AI-generated trading strategies—Position
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 11 Jun 2026 16:41
- Source
- Stock Traders Daily
Utah Medical Products (UTMD) Edges Higher, Testing Key Support Zone - MESA MA
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- Bölüm Sonu Canavarı
Utah Medical Products Inc. (UTMD) Q1 2024 Earnings: EPS of $1.09 Reported, Stock Gains Modestly - Earnings Power Value
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 26 May 2026 07:00
- Source
- Bölüm Sonu Canavarı
Utah Medical Products, Inc. (UTMD) Leadership & Management Team Analysis
This article provides an analysis of Utah Medical Products, Inc. (UTMD)'s leadership, management, and recent company updates. It highlights key personnel information, board appointments, insider transactions, and dividend announcements, alongside earnings reports and analytical p
- Tone
- Negative 39/100
- Event
- Earnings
- Published
- 15 May 2026 12:40
- Source
- Simply Wall Street
Brandes Investment Partners holds 14.12% of Utah Medical Products (NASDAQ: UTMD)
Brandes Investment Partners has filed an amended Schedule 13G, disclosing a beneficial ownership of 449,680 shares in Utah Medical Products (UTMD), which represents 14.12% of the company's class. The filing indicates that Brandes holds shared voting power over 412,007 of these sh
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 21:44
- Source
- Stock Titan
Utah Medical Products: I Can't Upgrade Shares Until Sales Stabilize (UTMD)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 14 May 2026 07:00
- Source
- Seeking Alpha
Utah Medical Products (NASDAQ: UTMD) Q1 2026 sales and profit decline
Utah Medical Products (UTMD) reported a decline in its Q1 2026 sales and profit compared to a strong prior year. Net sales decreased by 10.2% to $8,722k, primarily due to the loss of a major China distributor and an OEM customer, leading to a 14.4% drop in net income to $2,604k.
- Tone
- Negative 30/100
- Event
- Earnings
- Published
- 12 May 2026 20:09
- Source
- Stock Titan